SEC Company Response from X4 Pharmaceuticals, Inc (XFOR) (CIK 0001501697) (XFOR) — Nov 13, 2017
X4 Pharmaceuticals, Inc (XFOR) (CIK 0001501697)
Date: Nov. 13, 2017 · CIK: 0001501697 · Accession: 0001193125-17-340929
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-221050
Letter
Re: Arsanis, Inc.
November 13, 2017
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Dorrie Yale
Registration Statement on Form S-1
File No. 333-221050
Acceleration Request
Requested Date: November 15, 2017
Requested Time: 4:00 p.m., Eastern Standard Time
Ladies and gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Citigroup Global Markets Inc., Cowen and Company, LLC and Piper Jaffray & Co., as representatives of the several underwriters, hereby join Arsanis, Inc. in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-221050) (the “Registration Statement”) to become effective on Wednesday, November 15, 2017, at 4:00 p.m., Eastern Standard Time, or as soon as practicable thereafter.
Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.
[Signature Page Follows]
Very truly yours,
CITIGROUP GLOBAL MARKETS INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP November 13, 2017 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Dorrie Yale Re: Arsanis, Inc. Registration Statement on Form S-1 File No. 333-221050 Acceleration Request Requested Date: November 15, 2017 Requested Time: 4:00 p.m., Eastern Standard Time Ladies and gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Citigroup Global Markets Inc., Cowen and Company, LLC and Piper Jaffray & Co., as representatives of the several underwriters, hereby join Arsanis, Inc. in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-221050) (the “Registration Statement”) to become effective on Wednesday, November 15, 2017, at 4:00 p.m., Eastern Standard Time, or as soon as practicable thereafter. Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement. We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable. [Signature Page Follows] Very truly yours, CITIGROUP GLOBAL MARKETS INC. By: /s/ Russell Chong Name: Russell Chong Title: Managing Director COWEN AND COMPANY, LLC By: /s/ E. James Streator, III Name: E. James Streator, III Title: Managing Director PIPER JAFFRAY & CO. By: /s/ Christie L. Christina Name: Christie L. Christina Title: Managing Director Piper Jaffrey & Co. cc: René Russo, Pharm.D., BCPS, Arsanis, Inc. Michael D. Maline, Goodwin Procter LLP Edwin O’Connor, Goodwin Procter LLP Seo Salimi, Goodwin Procter LLP Steven D. Singer, Esq., Wilmer Cutler Pickering Hale and Dorr LLP Cynthia T. Mazareas, Esq., Wilmer Cutler Pickering Hale and Dorr LLP [Signature Page to Acceleration Request]